FNBT
ISEE

FineMark National Bank & Trust’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

FineMark National Bank & Trust’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-236
Closed -$1K – 1062
2016
Q4 		$1K Hold
236
– – ﹤0.01% 1259
2016
Q3 		$11K Buy
236
+90
+62% +$5.08K ﹤0.01% 929
2016
Q2 		$7K Sell
146
-218
-60% -$10.8K ﹤0.01% 1024
2016
Q1 		$15K Buy
+364
New +$18.5K ﹤0.01% 828

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FineMark National Bank & Trust's ISEE Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2017, closing a stake of 236 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in ISEE in Q1 2016 and held it in 4 quarters. The position peaked at $15K in Q1 2016. 100 funds tracked by Wall St. Rank hold ISEE as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 236 IVERIC bio, Inc. Common Stock shares in Q1 2017, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 4 quarters.
  • FineMark National Bank & Trust's IVERIC bio, Inc. Common Stock position peaked at $15K in Q1 2016.
  • 100 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.